Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Damnjan Pantic"'
Autor:
Đorđe Todorovic, Bojan Stojanovic, Milutinovic Filip, Đorđe Đorđevic, Milos Stankovic, Ivan Jovanovic, Marko Spasic, Bojan Milosevic, Aleksandar Cvetkovic, Dragce Radovanovic, Marina Jovanovic, Bojana S. Stojanovic, Damnjan Pantic, Danijela Cvetkovic, Dalibor Jovanovic, Vladan Markovic, Milica Dimitrijevic Stojanovic
Publikováno v:
Diagnostics, Vol 14, Iss 7, p 761 (2024)
This case report presents a unique instance of small bowel perforation caused by solitary metastasis from renal cell carcinoma (RCC), a rare and complex clinical scenario. The patient, a 59-year-old male with a history of RCC treated with nephrectomy
Externí odkaz:
https://doaj.org/article/34d5936f576b44d5a73398a8ec104ce7
Autor:
Milorad Stojadinovic, Milos Ivanovic, I. Vukovic, Damnjan Pantic, Slobodan M. Jankovic, Dragan Milovanovic, Miroslav M. Stojadinović
Publikováno v:
International Urology and Nephrology. 52:893-901
The aim of the study was to determine optimal threshold of the Prostate Health Index (Phi) for predicting aggressive prostate cancer (PCa), taking into account misclassification costs, prevalence, and plausible risk factors. This prospective cohort s
Publikováno v:
Srpski arhiv za celokupno lekarstvo (2020) 148(3-4):160-166
Srpski Arhiv za Celokupno Lekarstvo, Vol 148, Iss 3-4, Pp 160-166 (2020)
Srpski Arhiv za Celokupno Lekarstvo, Vol 148, Iss 3-4, Pp 160-166 (2020)
Introduction/Objective. The precursor prostate-specific antigen (proPSA) especially its isoform p2PSA is useful in the detection of prostate cancer (PCa). However, the prediction value of different p2PSA derivatives remains unclear. The aim of the st
Publikováno v:
Srpski arhiv za celokupno lekarstvo (2020) 148(5-6):292-298
Srpski Arhiv za Celokupno Lekarstvo, Vol 148, Iss 5-6, Pp 292-298 (2020)
Srpski Arhiv za Celokupno Lekarstvo, Vol 148, Iss 5-6, Pp 292-298 (2020)
Introduction/Objective. Prostate Health Index (PHI)-based nomograms were created by Lughezzani et al. (2012) and Zhu et al. (2015) for predicting prostate cancer (PCa) at extended biopsy. The aim of the study was to externally validate two nomograms